Literature DB >> 10591730

Cancer survival in Britain. Cancer chemotherapy costs money.

P G de Takats.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10591730      PMCID： PMC1117275     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Cancer survival in Britain is poorer than that of her comparable European neighbours.

Authors:  K Sikora
Journal:  BMJ       Date:  1999-08-21

2.  Prolonged cough and lung cancer: the need for more general practice research to inform clinical decision-making.

Authors:  B M Liedekerken; A Hoogendam; F Buntinx; T van der Weyden; H C de Vet
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

3.  Comparisons of colon-cancer survival among European countries: The Eurocare Study.

Authors:  M Sant; R Capocaccia; A Verdecchia; G Gatta; A Micheli; A Mariotto; T Hakulinen; F Berrino
Journal:  Int J Cancer       Date:  1995-09-27       Impact factor: 7.396

4.  The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis.

Authors:  F Buntinx; H Wauters
Journal:  Fam Pract       Date:  1997-02       Impact factor: 2.267

5.  Survival of women with breast cancer in Europe: variation with age, year of diagnosis and country. The EUROCARE Working Group.

Authors:  M Sant; R Capocaccia; A Verdecchia; J Estève; G Gatta; A Micheli; M P Coleman; F Berrino
Journal:  Int J Cancer       Date:  1998-08-31       Impact factor: 7.396

6.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.

Authors:  A R Feinstein; D M Sosin; C K Wells
Journal:  N Engl J Med       Date:  1985-06-20       Impact factor: 91.245
  6 in total
  1 in total

1.  Rationing certainly exists in treatment for cancer.

Authors:  D W Milligan
Journal:  BMJ       Date:  2000-03-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.